Ophthalmology

Rheumatology   

Questions discussed in this category



Patient previously trialed two anti-TNFi and Tocilizumab. Avoiding Rituximab due to positive JC virus testing. 

And have you ever seen it occur in isolation without any other manifestations of SLE? 

The patient has no extraocular features of a spondyloarthropathy and is on methotrexate. No active eye disease for past 1 year.

If so, when do you recommend timing for the cataract surgery? 

Are there specific features that suggest drug-induced uveitis versus de novo uveitis?

Patient was previously well controlled on methotrexate, which was discontinued during cancer treatment.


Papers discussed in this category


Ophthalmology, 2015-05

Retina,

Ophthalmic Res, 2018 Apr 10

Dev Ophthalmol, 2012 Apr 17

Arthritis Rheumatol, 2019 Aug 12

American journal of ophthalmology, 2017-11

Curr Opin Rheumatol,

Annals of the rheumatic diseases, 2012-08

Lupus,

Arthritis Rheumatol, 2020 Jan 07

J Rheumatol, 2013 Nov 15

Arthritis Res Ther, 2005 Mar 01

JAMA Ophthalmol, 2015 Oct

JAMA, 2022 Oct 11

Front Immunol, 2021 May 14

Ophthalmology, 2014-10

Br J Ophthalmol, 2015 Apr 22

Am J Ophthalmol,

Transplant Proc,

Int J Environ Res Public Health, 2021 Aug 01

BMC Rheumatol, 2021 Oct 01

Clin Ophthalmol, 2011 Oct 04

Ophthalmology and therapy, 2023 Aug 21

Journal of the American Academy of Dermatology, 2017 Oct 06

Annals of the rheumatic diseases, 2023 Oct 12

Arthritis Rheumatol, 2016 Oct 26

Arthritis care & research, 2017 Oct 09

The Journal of rheumatology, 2021 May 01

The British journal of ophthalmology, 1997 Feb